Karly N Hampshire

(±)-MDMA and its enantiomers: potential therapeutic advantages of R(-)-MDMA.

Psychopharmacology February 2018 Elizabeth G Pitts, Daniel W Curry, Karly N Hampshire et al.

The use of (±)-3,4-methylenedioxymethamphetamine ((±)-MDMA) as an adjunct to psychotherapy in the treatment of psychiatric and behavioral disorders dates back over 50 years. Only in recent years have controlled and peer-reviewed preclinical and clinical studies lent support to (±)-MDMA's hypothesized clinical utility. However, the clinical utility of (±)-MDMA is potentially mitigated by a range...